Dr. Wajeeha Razaq, MD

2013 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2013 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2013

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2013 were hypertension, cancer, high cholesterol and ischemic heart disease.

2014 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2014 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2014

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2014 were hypertension, cancer, high cholesterol and ischemic heart disease.

2015 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2015 were hospital care, inpatient care, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2015

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2015 were hypertension, cancer, high cholesterol and diabetes.

2016 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2016 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2016

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2016 were hypertension, cancer, high cholesterol and chronic kidney disease.

2017 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2017 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2017

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2017 were hypertension, cancer, high cholesterol and chronic kidney disease.

2018 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2018 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2018

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2018 were cancer, hypertension, high cholesterol and chronic kidney disease.

2019 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2019 were hospital care, inpatient care, and .

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2019

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2019 were cancer, hypertension, high cholesterol and depression.

2020 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2020 were hospital care, inpatient care, and .

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD in 2020

The most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated during 2020 were cancer, hypertension, high cholesterol and chronic kidney disease.

2021 Medicare Procedure Volume

The top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK during 2021 were hospital care, inpatient care, and .

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Wajeeha Razaq, MD for Medicare patients.

The highest averages for the top procedures that Dr. Wajeeha Razaq, MD treated as an oncologist in Oklahoma City, OK were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Wajeeha Razaq, MD.

Average of Total of Conditions of Medicare patients treated by Dr. Wajeeha Razaq, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Wajeeha Razaq, MD treated were hypertension, cancer, high cholesterol and chronic kidney disease.